AstraZeneca, Merck's Lynparza plows ahead in ovarian cancer with $1B-plus approval, phase 3 data

The year may be winding down, but AstraZeneca and Merck’s Lynparza sure isn’t. It picked up a blockbuster new approval late Wednesday and followed up the act by posting positive phase 3 data Thursday morning. U.S. regulators green-lighted the fast-growing PARP inhibitor in BRCA-mutated ovarian cancer patients who’ve responded partially or completely to an initial… Read More »

Dietician-Approved Post-Workout High-Fibre High-Protein Smoothie

Dietician-Approved Post-Workout High-Fibre High-Protein Smoothie It’s summer time and mangoes are in season! Amy Hopkins | 23 December 2018 SHARE THIS ON Total Time5 minutes Ingredients7 Count Dietician Sumaiya Essa is one of our #WHNextFitFoodie Top 10 contenders and she has an awesome post-workout smoothie! Check out her Instagram: @sumaiyadietitian for some helpful healthy food… Read More »

Cervical Cancer Death Rates Alarmingly High Among Black Women in Alabama

Although cervical cancer is a preventable and highly curable disease, a new report released by Human Rights Watch reveals that Black women in Alabama are dying of this cancer at more than twice the national average, reports The Guardian. Cervical cancer was once a major cause of death for American women, but the advent of… Read More »